Neuropsychopharmacology of ADHD Medications: Mechanisms of Action and Cognitive Outcomes

Authors

  • Motahareh Rahimi Borji, Bahman Kord Tamini

Keywords:

ADHD, Neuropharmacology, Cognitive Outcomes, Stimulant Medications, Non-Stimulant Medications, Methylphenidate, Atomoxetine, Executive Function, Pharmacotherapy, Cognitive Enhancemen.

Abstract

Background: Attention-deficit hyperactivity disorder (ADHD) is a prevalent neurodevelopmental disorder affecting cognitive and behavioral functions. Pharmacotherapy, including stimulants and non-stimulants,plays a crucial role in managing ADHD symptoms. However, the neuropharmacological mechanisms and cognitive effects of these medications remain under continuous investigation.

Downloads

Download data is not yet available.

References

Advokat, C., & Martino, J. (2020). Understanding ADHD: Pharmacological and non-pharmacological treatments. Reviews, Neuroscience & Biobehavioral 108, 467-478.

Downloads

Published

2025-01-01

How to Cite

Motahareh Rahimi Borji, Bahman Kord Tamini. (2025). Neuropsychopharmacology of ADHD Medications: Mechanisms of Action and Cognitive Outcomes . Pegem Journal of Education and Instruction, 15(1), 310–323. Retrieved from https://pegegog.net/index.php/pegegog/article/view/4094

Issue

Vol. 15 No. 1 (2025): PEGEGOG

Section

Article

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

NonCommercial — You may not use the material for commercial purposes.

No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.